MétaCan
Menu
Back to cohort
Record W4406288034 · doi:10.1093/ehjcvp/pvae090

Prevention is the key

2024· article· en· W4406288034 on OpenAlexaboutno aff
Stefan Agewall

Bibliographic record

VenueEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2024
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsnot available
Fundersnot available
KeywordsKey (lock)Computer scienceComputer security

Abstract

fetched live from OpenAlex

Should patients with acute coronary syndrome ( ACS) and a transient episode of new-onset atrial fibrillation ( AF) be given anticoagulant treatment? 1 , 2 AF is one of the most prevalent complications observed in patients with ACS. 3 -5 For this last issue of the year, Dr Sorrentino and co-workers from Italy have examined the overall risk of long-term adverse events of a transient episode of new-onset AF in patients with ACS.The authors used 7 observational studies, comprising 151 735 patients; 6597 experienced transient new-onset AF, which was associated with an increased risk of ischaemic stroke, recurrent AF, or all-cause mortality.The authors concluded that occurrence of transient new-onset AF is associated with an elevated long-term risk of stroke, recurrent AF, and all-cause mortality in patients with ACS.The paper is followed by an editorial by Dr Lip and co-workers, who concluded that future prospective studies should also include long-term monitoring to understand how AF relates to outcomes, and whether it is AF burden or AF density being the more important consideration.The clinical validation of wearable devices has the potential to see them being integrated into monitoring pathways.Cancer-associated thrombosis ( CAT) is a primary cardiovascular ( CV) complication encountered during cancer treatment, and venous thromboembolism ( VTE) could be the most prevalent CAT.The current guidelines in the field of oncology, including those laid by the National Comprehensive Cancer Net work , American Society of Clinical Oncology, and International Initiative on Thrombosis and Cancer, recommend providing anticoagulation therapy for a minimum of 6 months for cancer-associated VTE. 6 , 7 Incidence of arterial thromboembolism ( ATE) among ambulatory cancer patients varies by primary tumour site.In a paper from Canada, Dr Xu and coworkers conducted a systematic analysis, and included randomized trials comparing prophylactic anticoagulation to no anticoagulation among ambulatory cancer patients who initiated tumour-directed systemic therapy.The authors included 10 randomized controlled trials with 9875 patients with follow-up ranging from 3.3 to 68 ( median 6.6) months.While prophylactic anticoagulation did not reduce ATE risks overall, it conferred a protective effect among pancreatic cancer patients, without a detectable increase in major bleeding.The authors concluded that prophylactic anticoagulation did not reduce ATE risks among ambulatory cancer patients overall.However, we observed lower incidence of ATE among pancreatic cancer patients randomized to receive anticoagulation.All patients with an ACS should be treated with lipid-lowering therapy.Preferably with a high dose but we know that some patients

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.043
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Insufficient payload (model declined to judge)
Consensus categoriesInsufficient payload (model declined to judge)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.672
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0430.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.010

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.370
GPT teacher head0.453
Teacher spread0.083 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart Journal - Cardiovascular PharmacotherapySame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207